Area of research
Endocrinology, Diabetes and Metabolism · Surgery
Research interest
Research interests include Medicine, Internal medicine, MEN1, Context (archaeology), Acromegaly, and Temozolomide.
EndoCompass project: research roadmap for thyroid endocrinology
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study
Consensus statement by the French Society of Endocrinology (SFE) and French Society of Pediatric Endocrinology & Diabetology (SFEDP) on diagnosis of Cushing's syndrome
Pituitary MRI Features in Acromegaly Resulting From Ectopic GHRH Secretion From a Neuroendocrine Tumor: Analysis of 30 Cases
Factors influencing the levothyroxine dose in the hormone replacement therapy of primary hypothyroidism in adults
Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective Study
Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study
Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016
Metastatic Potential and Survival of Duodenal and Pancreatic Tumors in Multiple Endocrine Neoplasia Type 1
Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas
Time Until Partial Response in Metastatic Adrenocortical Carcinoma Long-Term Survivors
Ensuring Effective Prevention of Iodine Deficiency Disorders
Long-term results of the surgical management of insulinoma patients with MEN1: a Groupe d'étude des Tumeurs Endocrines (GTE) retrospective study
Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don't forget MEN1 genetic analysis
Frequent Large Germline<i>HRPT2</i>Deletions in a French National Cohort of Patients With Primary Hyperparathyroidism
Long-term efficacy and safety of subcutaneous pasireotide in acromegaly: results from an open-ended, multicenter, Phase II extension study
Prolactinomas resistant to standard doses of cabergoline: a multicenter study of 92 patients
Clinical Characteristics and Outcome of Acromegaly Induced by Ectopic Secretion of Growth Hormone-Releasing Hormone (GHRH): A French Nationwide Series of 21 Cases